Skip to main content

Table 1 Socio-demographic characters, anthropometric measurements, and basic lab findings among the studied groups

From: Real-time elastography “FibroScan” compared to simple non-invasive screening tools in the assessment of liver fibrosis in non-alcoholic fatty liver patients

Variable

Group I (n = 100)

Group II (n = 30)

P

Age (years), mean ± SD

47.1 ± 11.6

43.1 ± 9.9 0.086

0.086 (NS)

Sex

  

0.083 (NS)

 Male

60 (60%)

15 (50%)

 

 Female

40 (40%)

15 (50%)

 

DM

  

0.001 (HS)

 Non-diabetic

71 (71%)

30 (100%)

 

 Diabetic

29 (29%)

0 (0%)

 

Weight (kg)

94.09 ± 17.0

75.0 ± 13.22

 < 0.01(HS)

Height (cm)

167.6 ± 6.16

169.1 ± 6.72

0.253(NS)

BMI (kg/m2)

33.4 ± 5.34

26.1 ± 3.62

 < 0.01(HS)

Total cholesterol (mg/dl)

236.0 ± 17.7

123.1 ± 16.6

 < 0.001(HS)

HDL cholesterol

58.5 ± 8.33

86.2 ± 9.44

 < 0.001(HS)

LDL cholesterol

139.5 ± 9.71

82.1 ± 11.72

 < 0.001(HS)

TG (mg/dl)

161.0 ± 18.38

99.2 ± 6.82

 < 0.001(HS)

AST

35.8 ± 29.4

20.0 ± 5.8

 < 0.001(HS)

ALT

39.7 ± 29.8

19.1 ± 7.3

 < 0.001(HS)

T. bilirubin (mg/dl)

0.72 ± 0.17

0.86 ± 0.09

 < 0.031(S)

Albumin (g/dl)

4.15 ± 0.36

4.55 ± 0.43

 < 0.022(S)

INR

1.00 ± 0.01

1.00 ± 0.00

1.0 (NS)

Creatinine (mg/dl)

0.90 ± 0.15

0.91 ± 0.07

0.839 (NS)

Hemoglobin (mg/dl)

13.1 ± 1.85

12.9 ± 1.52

0.48 (NS)

WBCs (cell/mm3)

7171.4 ± 2043.91

6302.5 ± 1283.16

0.038 (S)

PLTs (× 103/mm3)

241.1 ± 74.77

241.9 ± 50.90

0.76 (NS)